Abstract:Objective To establish mouse allergic bronchial asthma (asthma) model and observe the effect of bacterial lysates (OM-85BV) on airway inflammation,as well as the expression of TGF-β1 and Foxp3 in serum and spleen.Methods Forty-eight 4 to 6 weeks healthy male BALB/c mice were used as research subjects and randomly divided into six groups,a:contral group,b:OM-85BV contral group,c:allergic asthma model,d:dexamethasone group (Dex group),e:OM-85BV A group,f:OM-85BV B group (the intervention time was prolonged 10 days than group e).BALB/c mice were sensitized and challenged by ovalbumin (OVA).Mice in groups c,d,e and f were intraperitoneally administered by antigen (OVA)-Al(OH)3 on days 1,8 and 15,others were administered by PBS.From the 17th day to the 26th day,mice in the group f were treated with OM-85BV and others were treated with normal saline.In the next days,mice in groups c,d,e and f were intranasal given OVA for 5 consecutive days.Additionally,mice in groups b,e and f were treated with OM-85BV before challenge,while mice in the group d were administered by Dex,others were treated with normal saline at the same dose.Twenty four hours after the last intranasal administration,mice were anesthetized and dissected.The TGF-β1 levels of blood serum were detected.The removed parts of lung tissue were for histological to observe airway inflammation and the thymuses were prepared for immunohistochemistry examination to detect the expression of Foxp3.The expression of TGF-β1 mRNA and Foxp3 mRNA in spleen were detected by Real time-PCR.Results Compared with groups a and b,lung tissue biopsies by HE staining from the asthma group showed obvious airway inflammation.The situation of groups d and f was significantly improved than group c while the differences between groups e and c were not evidently.TGF-β1 levels from the asthma group in blood serum were significantly lower than groups a and b while the levels of groups d and f were significantly improved than group c.The immunohistochemistry examination of Foxp3 in thymus didn' t show significant difference,but thymuses of group d were obviously smaller than other groups.Compared with the contral group (1.001±0.000),the levels of TGF-β1 mRNA from the asthma group (0.851±0.071) were significantly lower.The corresponding levels of groups d (1.085 ± 0.042) and f (1.292 ± 0.083) were significantly improved than group c (P ＜0.01).Compared with the contral group (1.001 ±0.000),the levels of Foxp3 mRNA from the asthma group (0.585 ± 0.192) were significantly lower.The corresponding levels of group f (2.074±0.037) were significantly improved than group c (P ＜0.01).Conclusions Administered by OM-85BV helps reduce airway inflammation in asthmatic mice and significantly improve the expression of TGF-β1 and Foxp3 of the peripheral blood and peripheral immune organs.The two may be the therapeutic targets to prevent the occurrence and development of airway inflammation in asthma.

Therapeutic Effects of Anti-B7-h3 Antibody in an Ovalbumin-Induced Mouse Asthma Model.

Fc Gamma Riiia Negatively Impacts Humoral Immune Responses But Not Overall Lung Inflammation In An Ovalbumin-Induced Allergic Asthma Mouse Model

Assessment of Tumor Growth Factor-Β1 Neutralizing Antibody in the Treatment of Allergic Rhinitis and Asthma.

Altered Frequency of NK Cells and Treg Cells by <i>Astragalus</i> Polysaccharide Combined with Budesonide in Asthma Model Mice

Anti-Cd69 Monoclonal Antibody Treatment Inhibits Airway Inflammation in A Mouse Model of Asthma

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma

Enhanced Local Foxp3 Expression in Lung Tissue Attenuates Airway Inflammation in A Mouse Model of Asthma

CCR3 Monoclonal Antibody Inhibits Airway Eosinophilic Inflammation and Mucus Overproduction in a Mouse Model of Asthma

Therapeutic efficacy of JEW-M449, an anti-TCTP monoclonal antibody, administered via the nasal route in a BALB/c mouse model of ovalbumin-induced acute asthma

CXCR4 Inhibitor Attenuates Ovalbumin-Induced Airway Inflammation and Hyperresponsiveness by Inhibiting Th17 and Tc17 Cell Immune Response.

The effects of resiquimod in an ovalbumin-induced allergic rhinitis model

Effect of Bacillus Calmette-Guerin Treatment on Airway Inflammation and T Regulatory Cells in Mice with Asthma

Effect of Anti-IL-9 Antibody on Inflammatory Airway of Asthmatic Mouse

The effect of Bruton's tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse

Effect of anti-CD8mAb on airway inflammation of Balb/c mice with respiratory syncytial virus-induced asthma

Impact of bacterial lysates on the expression of TGF-β1 and Foxp3 in mouse

Protective Effects of Astragaloside IV against Ovalbumin-Induced Lung Inflammation Are Regulated/Mediated by T-bet/GATA-3

4-1Bbl/4-1bb Costimulation Alleviates Airway Inflammation by Restoring Treg/Th17 Balance in Allergic Asthma

Antibody to Mclca3 Suppresses Symptoms in a Mouse Model of Asthma.

Effects of Bacillus Calmette-Guerin on airway inflammation, T helper cell differentiation and serum OVA-specific IgE levels in a mouse model of asthma